Isolde Gröll

842 citations
6 papers · 606 · 1 hit paper · h-index 6

Impact in

Papers in

    • Cancer Treatment and Pharmacology 2
    • PARP inhibition in cancer therapy 1
    • Cancer survivorship and care 1
    • Ovarian cancer diagnosis and treatment 1

Isolde Gröll

6 papers receiving 587 citations

Isolde Gröll's Hit Papers

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer 2022 · 329 citations
3290+1+2Years since publication100200300

Peers

Isolde Gröll
Comparison fields: 5 of 46
  • Cancer Research 220
  • Reproductive Medicine 85
  • Oncology 162
  • Genetics 98
  • Health Informatics 4
Replace Mustafa Deryal with:
Mustafa Deryal Germany
Peter Ledwon Germany
Alain Gratet France
Carsten Hielscher Germany
Charisios Karanikiotis Greece
Eva Maria Grischke Germany
Santiago González-Santiago Spain
Solange Moraes Sanches Brazil
Valentina Arcangeli Italy
Martin S. Hogg United Kingdom
Isolde Gröll relative to Mustafa Deryal Germany Mustafa Deryal's profile →
Citations per field
00.5×1.5×2×
Mustafa Deryal · 1×
Citations per year

Countries citing papers authored by Isolde Gröll

Since Specialization
Citations

This map shows the geographic impact of Isolde Gröll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isolde Gröll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isolde Gröll more than expected).

Fields of papers citing papers by Isolde Gröll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isolde Gröll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isolde Gröll. The network helps show where Isolde Gröll may publish in the future.

Co-authors

The 7 scholars most cited alongside Isolde Gröll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Isolde Gröll Line = papers co-authored together Isolde Gröll links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Hit paper breakdown →
2022329
2 2020131
3 201787
4 202330
5 201021
6 20108

About Isolde Gröll

Isolde Gröll is a scholar working on Oncology, Reproductive Medicine, Cancer Research, General Health Professions and Pulmonary and Respiratory Medicine, having authored 6 papers that have together received 606 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (1 paper), PARP inhibition in cancer therapy (1 paper), Mobile Health and mHealth Applications (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Advanced Breast Cancer Therapies (1 paper) and Cancer survivorship and care (1 paper). The work is most often cited by research in Cancer Research (220 citations), Reproductive Medicine (85 citations), Oncology (162 citations), Genetics (98 citations) and Health Informatics (4 citations). Isolde Gröll has collaborated with scholars based in Germany and Switzerland. Frequent co-authors include Harald Leo Sommer, Nadia Harbeck, Wolfgang Abenhardt, Marion Kiechle, Volker Heinemann, Hans‐Joachim Stemmler and H.G. Meerpohl. Their work appears in journals such as Oncology, The Lancet Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact